Before accessing this site, you agree that you have read and agree to the disclaimers at the bottom of this page.
Stock Charts AI Power Rank: 5.0
Power Rank trend -> Falling
Industry: Medical Care Facilities
Follow @stockchartsai on TwitterIn the past 20 trading days, DVA has been trading in a range between $141.86 and $135.95 (gray range band). Red lines on the chart represent key resistance levels and Green lines represent key support levels. As the price moves above the lines you will notice they turn green and red if price moves below a line.
The AI powered stock chart is in a Yellow zone which means the stock is transitioning zones. We would avoid this stock currently.
DaVita HealthCare Partners Inc $DVA entered a Yellow zone 1 days ago on the AI powered stock chart. Wall Street analysts have an AVG target price $113, a potential down side of -17.76% from the recent price of 137.41. The stock is trading 7.66% (potential upside) below its 52 week high of $147.93 and 92.15 % (potential downside) above its 52 week low of $71.51 - based on the recent price.
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers.
DaVita HealthCare (DVA) Laps the Stock Market: Here's Why The latest trading day saw DaVita HealthCare (DVA) settling at $139.96, representing a +1.46% change from its previous close. Source: Zacks Investment Research Mon, 22 Jul 2024 19:21:19 -0400 Sentiment: Neutral |
DaVita Inc. Schedules 2nd Quarter 2024 Investor Conference Call DENVER , July 18, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Tuesday, August 6, 2024, at 5:00 p.m. Eastern Time. Source: PRNewsWire Thu, 18 Jul 2024 14:00:00 -0400 Sentiment: Neutral |
DaVita HealthCare (DVA) Rises Higher Than Market: Key Facts DaVita HealthCare (DVA) reachead $137.72 at the closing of the latest trading day, reflecting a +1.3% change compared to its last close. Source: Zacks Investment Research Tue, 16 Jul 2024 19:05:28 -0400 Sentiment: Neutral |
DaVita (DVA) Gains 29.8% YTD: What's Driving the Stock? DaVita's (DVA) shares gain on the back of strong fundamentals. However, dependence on commercial payers can be a cause of concern. Source: Zacks Investment Research Tue, 16 Jul 2024 13:16:27 -0400 Sentiment: Positive |
Renal Denervation Devices Market Expected to Reach USD 387 Million by 2032 with a Remarkable 37.2% CAGR, According to Straits Research Renal Denervation Devices Market Size, Share & Trends Analysis Report By Technology (Radiofrequency-based, Ultrasound-based, Micro-infusion-based, Others), By End User (Hospitals & Clinics, Ambulatory surgery centers, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032 Renal Denervation Devices Market Size, Share & Trends Analysis Report By Technology (Radiofrequency-based, Ultrasound-based, Micro-infusion-based, Others), By End User (Hospitals & Clinics, Ambulatory surgery centers, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032 Source: GlobeNewsWire Tue, 16 Jul 2024 10:20:00 -0400 Sentiment: Neutral |
Stock Analyzed Each Night
Easily Upload Track Your Stocks
See Lists of Stocks Starting New Trends
The information contained on this website is solely for educational purposes, and does not constitute investment advice. The risk of trading in securities markets can be substantial. By accessing this site, you agree we are not liable, whether in contract, tort (including negligence) or otherwise, in respect of any damage, expense or other loss you may suffer arising out of such information or any reliance you may place upon such information from this site. Stocks, Futures and options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stock, futures and options markets. Don't trade with money you can't afford to lose. This website is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this website. The past performance of any trading system or methodology is not necessarily indicative of future results. Individual results may vary, and testimonials are not claimed to represent typical results. All testimonials are by real people, and may not reflect the typical purchaser’s experience, and are not intended to represent or guarantee that anyone will achieve the same or similar results. HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY, SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.